Back to mobile site

Haemonetics (HAE) PT Raised to $59 at Jefferies; Reiterates Buy

November 8, 2017 9:08 AM EST Send to a Friend
Jefferies raised its price target on Haemonetics (NYSE: HAE) to $59.00 (from $48.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login